Press release
Rising Genetic Disorders Drive Growth Of The Market Due To Increasing Parental Age And Mutation Correction Potential: The Driving Engine Behind Ribonucleic Acid (RNA) Editing Market Evolution in 2025
Ribonucleic Acid RNA Editing
Ribonucleic Acid (RNA) Editing Market Size Growth Forecast: What to Expect by 2025?
The market for RNA (Ribonucleic Acid) editing has seen significant expansion in the recent past. The market, worth $16.10 billion in 2024, is projected to reach $17.55 billion in 2025, registering a CAGR of 9.0%. The past growth can be attributed to a surge in demand for transient and reversible editing techniques, increased application in studies surrounding neurodegenerative diseases, growing cases of rare and orphan diseases, a spike in interest towards synthetic biology and bioengineering, and escalating academic and translational research initiatives.
How Will the Ribonucleic Acid (RNA) Editing Market Size Evolve and Grow by 2029?
Robust expansion is anticipated in the ribonucleic acid (RNA) editing market in the upcoming years, with a projection to reach $24.42 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.6%. This growth during the forecast period can be credited to factors such as the rising incidence of genetic ailments, an amplified emphasis on individualized medicine, growing utilization in cancer therapy, ongoing advancements in delivery mechanisms, and heightened support from governmental and regulatory entities. Key trends to watch in the forecast period encompass advancements in RNA editing platforms, emerging in vivo delivery technologies, technological strides in sequencing and transcriptomics, progress in transient gene modulation techniques, and the evolution of synthetic biology applications.
View the full report here:
https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-editing-global-market-report
What Drivers Are Propelling the Growth of Ribonucleic Acid (RNA) Editing Market Forward?
The escalating incidence of genetic disorders is projected to accelerate the expansion of the ribonucleic acid (RNA) editing market. Genetic disorders, diseases triggered by changes or aberrations in genetic material either passed down from parents or occurring spontaneously, are on the rise due to increasing parental age. Older parents carry a greater risk of transmitting chromosomal abnormalities. Ribonucleic acid (RNA) editing ameliorates genetic disorders by rectifying mutations at the RNA level, enabling cells to generate functional proteins without modifying the fundamental DNA. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a public health institution based in the U.S., reported that sickle cell disease (SCD) impacts around 100,000 individuals in the United States. Thus, the escalation of genetic disorders is propelling the expansion of the ribonucleic acid (RNA) editing market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27407&type=smp
Which Emerging Trends Are Transforming the Ribonucleic Acid (RNA) Editing Market in 2025?
Key players in the ribonucleic acid (RNA) editing market are concentrating their efforts on the creation of novel methodologies, such as in vivo gene editing, to facilitate the precise and effective correction of pathogenic mutations within living organisms. In vivo gene editing involves the direct adjustment of genes within the cells of a living entity to rectify genetic anomalies or modify gene function for therapeutic application. For example, in April 2024, the Rett Syndrome Research Trust, a United States-based non-profit organisation, initiated the MECP2 Editing Consortium aiming to progress gene editing treatments for Rett syndrome. This project unites six premier laboratories to develop DNA and RNA editing therapies that tackle the genetic origin of Rett syndrome, with the goal of quickening their progression to clinical testing. The project's collaborative architecture encourages swift advancement by combining expertise to produce precise and potentially healing solutions for this severe neurological disorder.
What Are the Key Segments in the Ribonucleic Acid (RNA) Editing Market?
The ribonucleic acid (RNA) editing market covered in this report is segmented
1) By Type: Messenger Ribonucleic Acid (RNA) Modification, Transfer Ribonucleic Acid (RNA) Modification, Ribosomal Ribonucleic Acid (RNA) Modification
2) By Technique: Insertion Or Deletion, Deamination
3) By Application: Cancer, Genetic Disorders, Temporary Maladies
Subsegments:
1) By Messenger Ribonucleic Acid (MRNA) Modification: Base Editing, Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing, Site-Directed Ribonucleic Acid(RNA) Editing
2) By Transfer Ribonucleic Acid (TRNA) Modification: Pseudouridylation, Transfer Ribonucleic Acid Splicing, Inosine Modification
3) By Ribosomal Ribonucleic Acid (Rrna) Modification: Pseudouridylation, Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation, Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27407&type=smp
Who Are the Key Players Shaping the Ribonucleic Acid (RNA) Editing Market's Competitive Landscape?
Major companies operating in the ribonucleic acid (RNA) editing market are Moderna Inc., Arcturus Therapeutics Holdings Inc., CureVac AG, Beam Therapeutics Inc., EdiGene Inc., Ethris GmbH, Deep Genomics Incorporated, ProQR Therapeutics NV, ReCode Therapeutics, Capstan Therapeutics Inc., TriLink BioTechnologies, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Rznomics Inc., Airna Biotech S.L., hC Bioscience Inc., Korro Bio Inc., Shape TX, and Turn Biotechnologies.
What Geographic Markets Are Powering Growth in the Ribonucleic Acid (RNA) Editing Market?
North America was the largest region in the ribonucleic acid (RNA) editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27407
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Genetic Disorders Drive Growth Of The Market Due To Increasing Parental Age And Mutation Correction Potential: The Driving Engine Behind Ribonucleic Acid (RNA) Editing Market Evolution in 2025 here
News-ID: 4171727 • Views: …
More Releases from The Business Research Company
Key Drivers Reshaping the Purvalanol A (CDK Inhibitor) Market: Increasing Preval …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Purvalanol A (CDK Inhibitor) Market Size Growth Forecast: What to Expect by 2025?
The market size for purvalanol A (CDK inhibitor) has witnessed a substantial expansion in the past few years. It is projected to escalate from $0.58 billion in 2024 to $0.64 billion in 2025, with a compound…
Growing Emphasis On Personalized Medicine Driving The Market Due To Advances In …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Polygenic Risk Score Services Market Size Growth Forecast: What to Expect by 2025?
The market size for polygenic risk score services has seen considerable growth in recent years. Anticipated to increase from $1.24 billion in 2024 to $1.45 billion in 2025, it projects a compound annual growth rate (CAGR)…
Future of the Global Pharmaceutical Unit-Dose Packaging Market: Trends, Innovati …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pharmaceutical Unit-Dose Packaging Market Size Growth Forecast: What to Expect by 2025?
The market size of the pharmaceutical unit-dose packaging industry has experienced quick expansion in the recent past. The market, valued at $48.78 billion in 2024, is projected to rise to $54.50 billion in 2025, reflecting a compound…
Personal Care Product Testing Market Poised to Hit $10.37 Billion by 2029 with A …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Personal Care Product Testing Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the market size for personal care product testing has seen robust growth. It's projected to increase from $7.28 billion in 2024 to $7.84 billion in 2025, with a compound annual growth…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
